BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1916923)

  • 1. The relationship between MHC restricted and allospecific T cell recognition.
    Lechler R; Batchelor R; Lombardi G
    Immunol Lett; 1991 Jul; 29(1-2):41-50. PubMed ID: 1916923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allorecognition of DR1 by T cells from a DR4/DRw13 responder mimics self-restricted recognition of endogenous peptides.
    Lombardi G; Sidhu S; Batchelor JR; Lechler RI
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4190-4. PubMed ID: 2657745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition.
    Coppin HL; Carmichael P; Lombardi G; L'Faqihi FE; Salter R; Parham P; Lechler RI; de Preval C
    Eur J Immunol; 1993 Feb; 23(2):343-9. PubMed ID: 8436170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses.
    Lechler RI; Heaton T; Barber L; Bal V; Batchelor JR; Lombardi G
    Immunol Lett; 1992 Sep; 34(1):63-9. PubMed ID: 1478706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alloreactive and self-restricted CD4+ T cell response directed against a single MHC class II/peptide combination.
    Kovalik JP; Singh N; Mendiratta SK; Martin WD; Ignatowicz L; Van Kaer L
    J Immunol; 2000 Aug; 165(3):1285-93. PubMed ID: 10903728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression.
    Gallon L; Watschinger B; Murphy B; Akalin E; Sayegh MH; Carpenter CB
    Transplantation; 1995 Feb; 59(4):612-6. PubMed ID: 7878766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are primary alloresponses truly primary?
    Lombardi G; Sidhu S; Daly M; Batchelor JR; Makgoba W; Lechler RI
    Int Immunol; 1990; 2(1):9-13. PubMed ID: 1708274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Existence of MHC class I-restricted alloreactive CD4+ T cells reacting with peptide transporter-deficient cells.
    Kobayashi H; Kimura S; Aoki N; Sato K; Celis E; Katagiri M
    Immunogenetics; 2001 Oct; 53(8):626-33. PubMed ID: 11797095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DR alpha beta dimers released from complexes with invariant chain fail to stimulate alloreactive T cell clones.
    Demotz S
    Eur J Immunol; 1993 Sep; 23(9):2100-8. PubMed ID: 8370392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis of allorecognition of major histocompatibility complex molecules by T lymphocytes.
    Lombardi G; Lechler R
    Ann Ist Super Sanita; 1991; 27(1):7-14. PubMed ID: 1958030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary alloreactive cytotoxic T-lymphocytes are not commonly restricted by self-HLA class I antigens.
    Young NT; Roelen DL; Wood KJ; Welsh KI; Morris PJ; Dallman MJ
    Hum Immunol; 1996 Sep; 50(1):38-46. PubMed ID: 8872173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide-mediated modulation of T-cell allorecognition.
    Eckels DD; Gorski J; Rothbard J; Lamb JR
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8191-5. PubMed ID: 2973061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structural basis of T-cell allorecognition.
    Whitelegg A; Barber LD
    Tissue Antigens; 2004 Feb; 63(2):101-8. PubMed ID: 14705981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of class II beta-chain amino acid residues 85 and 86 in T-cell allorecognition.
    Eckels DD; Geiger MJ; Sell TW; Gorski JA
    Hum Immunol; 1990 Mar; 27(3):240-53. PubMed ID: 1692822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation.
    Carstens C; Newman DK; Bohlen H; König A; Koch N
    Int Immunol; 2000 Nov; 12(11):1561-8. PubMed ID: 11058576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen recognition by MHC-incompatible cells of a human mismatched chimera.
    Roncarolo MG; Yssel H; Touraine JL; Bacchetta R; Gebuhrer L; De Vries JE; Spits H
    J Exp Med; 1988 Dec; 168(6):2139-52. PubMed ID: 2462006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonrandom selection of T cell specificities in anti-HLA-DR responses. Sequence motifs of the responder HLA-DR allele influence T cell recruitment.
    Weyand CM; Hicok KC; Goronzy JJ
    J Immunol; 1991 Jul; 147(1):70-8. PubMed ID: 2051028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
    Singer A; Kruisbeek AM; Andrysiak PM
    J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular basis of allorecognition.
    Sherman LA; Chattopadhyay S
    Annu Rev Immunol; 1993; 11():385-402. PubMed ID: 8476567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell recognition of allopeptides in context of syngeneic MHC.
    Liu Z; Braunstein NS; Suciu-Foca N
    J Immunol; 1992 Jan; 148(1):35-40. PubMed ID: 1530797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.